You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mast cell leukemia (MCL)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

Not yet recruiting
  • Advanced Systemic Mastocytosis
  • (no location specified)
Nov 2, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
Dec 14, 2021

CD5+ Relapsed/Refractory Hematopoietic Malignancies, Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL) Trial

Not yet recruiting
  • CD5+ Relapsed/Refractory Hematopoietic Malignancies
  • +5 more
  • CT125A cells
  • Cyclophosphamide, fludarabine
  • (no location specified)
Feb 19, 2021

Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With

Completed
Has Results
  • Acute Undifferentiated Leukemia
  • +10 more
  • bioelectric impedance analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 30, 2020

Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Lymphoma, Mantle-Cell
  • (no location specified)
Dec 22, 2022

Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) Trial in

Completed
Has Results
  • Systemic Mastocytosis, Aggressive (ASM)
  • +2 more
  • Stanford, California
  • +2 more
Sep 19, 2018

Hematological Malignancies Trial in United States (KPG-818)

Recruiting
  • Hematological Malignancies
  • Sacramento, California
  • +9 more
Jul 4, 2022

T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

Terminated
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma
  • Saint Louis, Missouri
  • +1 more
Jan 18, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)

    Recruiting
    • Hematologic Malignancies
    • Torrance, California
    • +51 more
    Jan 12, 2023

    Hematologic Cancer Trial in Israel, United States (ABBV-101)

    Not yet recruiting
    • Hematologic Cancer
    • Lone Tree, Colorado
    • +7 more
    Feb 22, 2023

    Mast Cells and Prognosis in Acute Myocardial Infarction

    Not yet recruiting
    • Inflammation
    • +2 more
    • Tryptase
    • (no location specified)
    Apr 5, 2023

    Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
    • Basking Ridge, New Jersey
    • +4 more
    Dec 1, 2022

    Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)

    Active, not recruiting
    • Gastrointestinal Stromal Tumors
    • +2 more
    • Scottsdale, Arizona
    • +25 more
    Apr 16, 2021

    B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16

    Recruiting
    • B-cell Chronic Lymphocytic Leukemia
    • +3 more
    • Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
    • +5 more
    • Duarte, California
    • +12 more
    Jun 16, 2022

    Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +8 more
    • Iopofosine I 131 single dose
    • +2 more
    • Redlands, California
    • +42 more
    Dec 30, 2022

    Phase I: Relapsed or Refractory B-cell Malignancies, Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma, Phase II

    Active, not recruiting
    • Phase I: Relapsed or Refractory B-cell Malignancies
    • +2 more
    • Beijing, China
    • +22 more
    Dec 8, 2022

    Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

    Recruiting
    • Follicular Lymphoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Scottsdale, Arizona
    • +2 more
    Jan 5, 2023

    Mantle Cell Lymphoma Trial in China (400mg of TQB3909 tablets, 600mg of TQB3909 tablets)

    Recruiting
    • Mantle Cell Lymphoma
    • 400mg of TQB3909 tablets
    • 600mg of TQB3909 tablets
    • Beijing, Beijing, China
    • +27 more
    Oct 26, 2023

    Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Chicago, Illinois
      Northwestern University
    Feb 16, 2023

    Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

    Not yet recruiting
    • Myeloid Malignancy
    • Acute Myeloid Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer, Case Comprehensive Cancer C
    Nov 8, 2023

    Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)

    Recruiting
    • Acute Monocytic Leukemia
    • Newly Diagnosed
    • Suzhou, Jiangsu, China
      The First Affliated Hospital of Soochow University
    Oct 3, 2022